This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

3 Mar 2011

Signs: A Burst of Biotech Buyouts in 2011

Buyouts offer the only other lucrative exit strategy for venture backers.

All signs now point to a burst of biotech buyouts in 2011. The latest one reported by Bloomberg highlights the recent deals for Plexxikon and ProStrakan as indications that Japan's pharma companies are going to use their cache of cash to snap up more drug developers.


Bloomberg's numbers indicate that there was a 30 percent jump in the number of overseas deals completed by Japan's pharma companies in the past year, with a 72 percent spike in premiums. The business news service totted up 34 deals in the last 12 mon

Related News